Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

204

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Alzheimer's Disease

Interventions

DRUG

Rivastigmine, memantine

Trial Locations (1)

Département de Gérontologie Clinique, Limoges